DUBLIN, May 19, 2015 /PRNewswire/ --Research and Markets

(http://www.researchandmarkets.com/research/hdsx2f/bone) has announced the addition of the "Bone Morphogenetic Proteins Market (Types : rhBMP-2 and rhbmp-7; Applications: Spinal Fusion, Trauma, Reconstructive and Oral - Maxillofacial) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2014 - 2022" report to their offering.

The global bone morphogenetic proteins market is studied based on the types of recombinant BMPs, applications, and geography. Based on recombinant BMP types, the market has been further segmented into two major segments namely, rhBMP-2 and liquid rhBMP-7. Among the type segments, the rhBMP-2 segment accounted for the largest share (in terms of revenue) of the market in 2013. rhBMP-2 has been widely accepted by physicians and surgeons across the globe due to their effectiveness in treating lower back spinal fusions. rhBMP-7 on the other hand is expected to completely diminish from the market in the future due to withdrawal of OP-1/Opgenra from the market since August 2014.

In terms of application, spinal fusion currently accounts for the largest share of the market, followed by trauma. However, the reconstructive segment is likely to grow at a low CAGR during the forecast period from 2014 to 2022. The reason for sluggish growth is limited usage of BMP products for reconstructive surgery and presence of numerous well-established alternative bone graft substitutes.

In terms of regional distribution, North America currently accounts for the largest share of the bone morphogenetic proteins market, followed by Europe.

Furthermore, North America, with a market share of over 70%, is expected to dominate the industry during the forecast period. This leadership would be witnessed due to high awareness about BMP products, availability of premium priced recombinant BMP products, and soaring number of spinal fusion procedures.

Furthermore, highest growth of this industry is expected to emerge in Asia Pacific during the forecast period. The global bone morphogenetic proteins market is characterized by three players namely Medtronic plc, Olympus Biotech, and Cellumed.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Executive Summary

Chapter 3 Market Overview

Chapter 4 Bone Morphogenetic Proteins Market, by Types

Chapter 5 Bone Morphogenetic Proteins Market, by Application

Chapter 6 Bone Morphogenetic Proteins Market, by Geography

Chapter 7 Recommendation

Chapter 8 Company Profiles

- Cellumed Co, Ltd.
- Medtronic plc
- Stryker Corporation

For more information visit http://www.researchandmarkets.com/research/hdsx2f/bone

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets